2022
DOI: 10.1111/tid.13802
|View full text |Cite
|
Sign up to set email alerts
|

Serological testing on the ADVIA Centaur system for human immunodeficiency virus, hepatitis B virus, and hepatitis C virus in specimens from deceased and living individuals demonstrates equivalent resultsƚ

Abstract: The information in this paper is based on research results that are not commercially available. The products/features (mentioned herein) are not commercially available in all countries. Their future availability cannot be guaranteed.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
references
References 16 publications
0
0
0
Order By: Relevance